Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.
about
Implantable defibrillators versus medical therapy for cardiac channelopathiesImplantable defibrillators versus medical therapy for cardiac channelopathiesHigh-throughput sequencing for biology and medicineCardiovascular genomicsHeart failure: advanced development in genetics and epigeneticsHypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?Genetic testing for long QT syndrome and the category of cardiac ion channelopathies.Genetics of long QT syndrome.RNA interference-based therapeutics for inherited long QT syndromeNext-generation sequencing: from understanding biology to personalized medicine.The Genetic Challenges and Opportunities in Advanced Heart FailureHRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011Identification and functional analysis of a new putative caveolin-3 variant found in a patient with sudden unexplained deathImpact of genetics on the clinical management of channelopathies.Successful implantation of an intracardiac defibrillator in an infant with long QT syndrome and isolated noncompaction of the ventricular myocardium.Inherited cardiac arrhythmias: diagnosis, treatment, and prevention.Challenges of genetic testing in adolescents with cardiac arrhythmia syndromes.Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3.A Rapid, High-Quality, Cost-Effective, Comprehensive and Expandable Targeted Next-Generation Sequencing Assay for Inherited Heart Diseases.Paralogous annotation of disease-causing variants in long QT syndrome genes.Personalized medicine in cardiovascular diseases.Targeted next-generation sequencing of candidate genes reveals novel mutations in patients with dilated cardiomyopathyInherited Arrhythmias - Where do we Stand?Genetic testing in heritable cardiac arrhythmia syndromes: differentiating pathogenic mutations from background genetic noise.Post-mortem Whole exome sequencing with gene-specific analysis for autopsy-negative sudden unexplained death in the young: a case series.Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic CardiomyopathyQuantitative PCR as an alternative in the diagnosis of long-QT syndromeAlmanac 2011: Cardiac Arrhythmias and Pacing. The National Society Journals Present Selected Research that has Driven Recent Advances in Clinical Cardiology.The investigation of sudden arrhythmic death syndrome (SADS)-the current approach to family screening and the future role of genomics and stem cell technology.Sudden unexpected death in epilepsy genetics: Molecular diagnostics and preventionInterpreting secondary cardiac disease variants in an exome cohort.Genotype-phenotype relationship in patients with arrhythmogenic right ventricular cardiomyopathy caused by desmosomal gene mutations: A systematic review and meta-analysis.Genetic variants for long QT syndrome among infants and children from a statewide newborn hearing screening program cohortAllele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.Mechanisms of disease: hypertrophic cardiomyopathy.Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy.Understanding cardiovascular disease: a journey through the genome (and what we found there).Genetics of sudden cardiac death in children and young athletes.Can an athlete have too much ticker? Hypertrophic cardiomyopathy in young athletes.Brugada syndrome: an update.
P2860
Q24186596-DDC10A78-3938-45E9-A104-88572767924AQ24194254-36EB7059-3A3C-4AD2-9417-7DA067BFAE03Q26823498-313EA9C5-8754-4BEC-8499-43134AF231E2Q26995980-BBEB3225-B56F-4E5B-AFA0-8D1205D67AAAQ28080771-0F1AB24F-0ED1-4371-9FAD-D2EE7E5B8286Q30430827-2FBA24F8-9055-4E17-9227-A389CA55E60AQ33161629-C2082AC7-A16F-4CD1-AF3C-81CFBBC914BCQ33164422-6C759A25-5AE1-497C-A0AF-E3DC2D457BDBQ33166507-4B019B42-1839-4002-A84B-84E78B33A71FQ33565443-05356B3A-02F8-4C3F-94B0-9FE1204375EAQ33653498-84F45254-70AC-4D89-AB99-0152B8C1958DQ33815633-34FFC226-C7BA-43C2-BD5B-0242362B7FE2Q33943558-150ED4CC-F170-4B08-85AA-C3F893A63DF8Q34036797-0215756F-1F41-49A9-A74E-FD129675BE09Q34636858-B77263C4-14D5-4B47-BEAF-A3878E904658Q35276074-880D119A-5300-4490-AB02-CC1B84EDF586Q35672893-E74F431F-CA86-4EE8-98C1-10FC760ACBF2Q35974167-7E60C2B1-2128-4A75-BBBF-3EA666814B2AQ36054858-49322D10-D711-4EE8-B6FD-285D16897ADFQ36266996-20E855EC-554F-4626-B32E-F4F9495E444CQ36306729-A5A136D0-E3E0-4310-B686-E482BD7F3901Q36369239-3DEE014D-5400-4A56-BE02-4506336A79ADQ36458789-B9E51D41-F004-427A-B9BE-A62984139E57Q36994901-0BF2CF24-DC33-4D41-9DE7-3312CD63F3ACQ37002975-D52F0326-0179-453E-9A59-15CFD1CB05FEQ37003315-F935479D-6A7F-4408-958B-ACF873065BE2Q37019786-0B391A86-DF31-4C10-8D05-2AE357B420D7Q37066818-CD67DE2E-464A-4C9B-B4F1-FE840B671819Q37165579-5F54E374-1ADA-4B9D-A3B5-D06756B7B36FQ37279519-DD1721BB-6D7B-4FF1-82BD-F244B154F22EQ37460645-C5F17650-AAFC-4B5E-A3EC-2A2F26379C56Q37605121-0510AB58-1A1A-4D4F-AE5E-0D8222B8FDD4Q37620056-C99C5257-D96A-4364-B11A-F20958D84C48Q37711518-200AE1E6-46F0-4BDB-8CAF-05E74CD226CCQ37949516-9EDF192F-C2FC-4976-A438-271717654A57Q37980020-2F2B4D5F-C9C6-4FD9-A326-E009A0466294Q38021453-2B7DAFBE-AB2B-4C24-ACEA-BA148F60DAC8Q38028676-17ABD5C2-C86D-47E9-BDE1-0FF1941F8A3DQ38030645-E3AD28EE-6D82-40A0-A02B-2DC0D5A71BBCQ38086845-2239F505-F236-4D71-809C-D56AAD385DB0
P2860
Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genetic testing for potentiall ...... opathies in clinical practice.
@ast
Genetic testing for potentiall ...... opathies in clinical practice.
@en
Genetic testing for potentiall ...... opathies in clinical practice.
@nl
type
label
Genetic testing for potentiall ...... opathies in clinical practice.
@ast
Genetic testing for potentiall ...... opathies in clinical practice.
@en
Genetic testing for potentiall ...... opathies in clinical practice.
@nl
prefLabel
Genetic testing for potentiall ...... opathies in clinical practice.
@ast
Genetic testing for potentiall ...... opathies in clinical practice.
@en
Genetic testing for potentiall ...... opathies in clinical practice.
@nl
P2860
P1433
P1476
Genetic testing for potentiall ...... opathies in clinical practice.
@en
P2093
David J Tester
Michael J Ackerman
P2860
P304
P356
10.1161/CIRCULATIONAHA.109.914838
P407
P577
2011-03-01T00:00:00Z